ATE533845T1 - Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken - Google Patents

Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken

Info

Publication number
ATE533845T1
ATE533845T1 AT08163005T AT08163005T ATE533845T1 AT E533845 T1 ATE533845 T1 AT E533845T1 AT 08163005 T AT08163005 T AT 08163005T AT 08163005 T AT08163005 T AT 08163005T AT E533845 T1 ATE533845 T1 AT E533845T1
Authority
AT
Austria
Prior art keywords
polypeptide
signaling sequences
expression
libraries
eukaryotic signaling
Prior art date
Application number
AT08163005T
Other languages
English (en)
Inventor
Jeff Gray
Joe Buechler
Uday Veeramallu
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE533845T1 publication Critical patent/ATE533845T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT08163005T 2002-02-13 2003-02-13 Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken ATE533845T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/076,802 US7094579B2 (en) 2002-02-13 2002-02-13 Eukaryotic signal sequences for prokaryotic expression

Publications (1)

Publication Number Publication Date
ATE533845T1 true ATE533845T1 (de) 2011-12-15

Family

ID=27732544

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08163005T ATE533845T1 (de) 2002-02-13 2003-02-13 Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
AT03739833T ATE406439T1 (de) 2002-02-13 2003-02-13 Eukaryontische signalsequenzen für polypeptid- expressions- und polypeptid- präsentationsbibliotheken

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03739833T ATE406439T1 (de) 2002-02-13 2003-02-13 Eukaryontische signalsequenzen für polypeptid- expressions- und polypeptid- präsentationsbibliotheken

Country Status (9)

Country Link
US (5) US7094579B2 (de)
EP (2) EP2060628B1 (de)
JP (2) JP4303596B2 (de)
AT (2) ATE533845T1 (de)
AU (1) AU2003225578B2 (de)
CA (1) CA2475929C (de)
DE (1) DE60323210D1 (de)
DK (2) DK2060628T3 (de)
WO (1) WO2003068956A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097840B2 (en) 2000-03-16 2006-08-29 Genentech, Inc. Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
US7094579B2 (en) * 2002-02-13 2006-08-22 Xoma Technology Ltd. Eukaryotic signal sequences for prokaryotic expression
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US8293503B2 (en) 2003-10-03 2012-10-23 Promega Corporation Vectors for directional cloning
CA2541177A1 (en) * 2003-10-03 2005-09-22 Promega Corporation Vectors for directional cloning
PL1737962T3 (pl) * 2004-03-24 2011-02-28 Domantis Ltd Uniwersalny lider GAS1
ATE466090T1 (de) * 2004-12-07 2010-05-15 Lonza Ag Rhamnosepromotor-expressionssystem
PL1824961T3 (pl) 2004-12-07 2017-05-31 Lonza Ltd Układ ekspresji operonu melibiozy
CN103451164A (zh) 2006-07-14 2013-12-18 诺维信股份有限公司 用于产生具有生物学活性的分泌型多肽的方法
GB0810154D0 (en) * 2008-06-04 2008-07-09 Avecia Biolog Ltd Expression vector
US8546307B2 (en) * 2008-10-03 2013-10-01 Xoma Technology, Ltd. Triple tag sequence and methods of use thereof
SI2401373T1 (sl) * 2009-02-25 2014-02-28 Nextera As Signalni sekvenčno neodvisen pix prikaz faga
WO2010117420A2 (en) 2009-03-30 2010-10-14 Pacific Biosciences Of California, Inc. Fret-labeled compounds and uses therefor
US20140038842A1 (en) 2010-12-28 2014-02-06 Xoma Technology Cell surface display using pdz domains
EP2670847B1 (de) 2011-02-03 2016-10-05 XOMA Technology Ltd. Verfahren und materialien zur verbesserten funktionellen proteinexpression bei bakterien
RU2746407C1 (ru) 2012-02-23 2021-04-13 Стейдж Селл Терапеутикс Гмбх Хроматографическое выделение клеток и других сложных биологических материалов
EP3578660A1 (de) 2012-07-05 2019-12-11 F. Hoffmann-La Roche AG Expressions- und sekretionssystem
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
US11248238B2 (en) 2015-10-22 2022-02-15 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
JP7194020B2 (ja) 2015-10-22 2022-12-21 ジュノ セラピューティクス ゲーエムベーハー 細胞の培養方法ならびにそのためのキットおよび装置
US10954500B2 (en) 2015-10-23 2021-03-23 Fred Hutchinson Cancer Research Center Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
CN105734061B (zh) * 2016-03-25 2019-07-23 中国农业科学院生物技术研究所 从毕赤酵母中分离的鼠李糖诱导型启动子及其应用
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
EP3444269A1 (de) 2017-08-17 2019-02-20 National Research Council of Canada Systeme und methoden für die produktion von diphteria-giftstoff-polypeptiden
US11795579B2 (en) 2017-12-11 2023-10-24 Abalone Bio, Inc. Yeast display of proteins in the periplasmic space
EP3874024A1 (de) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Verfahren zur selektion und stimulation von zellen und vorrichtung dafür
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
IT201900006656A1 (it) 2019-05-08 2020-11-08 Salvagnini Italia Spa Macchina piegatrice per lamiere metalliche
KR20220145877A (ko) * 2020-02-25 2022-10-31 모멘타 파머슈티컬스 인코포레이티드 글리칸의 시알화를 위한 효소
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
CN116284288A (zh) * 2023-02-01 2023-06-23 深圳大学 莱茵衣藻分泌导肽和转基因莱茵衣藻及其构建方法与应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3852304T3 (de) 1987-03-02 1999-07-01 Enzon Labs Inc., Piscataway, N.J. Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9011861D0 (en) 1990-05-26 1990-07-18 Beecham Group Plc Novel compounds
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
EP0585287B1 (de) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Verfahren zur herstellung von spezifischen bindungspaargliedern
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE4022940A1 (de) 1990-07-19 1992-01-23 Bosch Gmbh Robert Einrichtung zur temperatursteuerung eines messwiderstands
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
DE4122598C1 (de) * 1991-07-08 1992-07-30 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, 6900 Heidelberg, De
AU665025B2 (en) 1991-09-23 1995-12-14 Cambridge Antibody Technology Limited Production of chimeric antibodies - a combinatorial approach
US5470997A (en) 1992-04-06 1995-11-28 Biosite Diagnostics Incorporated Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
EP0985033A4 (de) 1997-04-04 2005-07-13 Biosite Inc Polyvalente und polyklonale bibliotheken
US6555310B1 (en) * 1997-04-04 2003-04-29 Biosite Diagnostics, Inc. Polyclonal libraries
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
JP3374052B2 (ja) 1997-07-28 2003-02-04 株式会社堀場製作所 オゾン測定装置
US5932445A (en) 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
US6545140B1 (en) * 1998-07-13 2003-04-08 University Of Georgia Research Foundation, Inc. DNA encoding an avian beta-defensin and uses thereof
ES2257287T3 (es) 1999-02-12 2006-08-01 Amgen Inc. Composiciones de leptina glicosiladas y metodos relacionados.
US6794132B2 (en) 1999-10-02 2004-09-21 Biosite, Inc. Human antibodies
US7094579B2 (en) 2002-02-13 2006-08-22 Xoma Technology Ltd. Eukaryotic signal sequences for prokaryotic expression
DE20207301U1 (de) 2002-05-10 2002-12-19 Eichler-Stahlberg, Alke, 93059 Regensburg Expressionssystem für synthetische Gene in Mikroalgen
CN103929153B (zh) 2013-01-11 2016-12-28 北大方正集团有限公司 一种倍频处理方法和装置

Also Published As

Publication number Publication date
JP2009131286A (ja) 2009-06-18
JP2005517407A (ja) 2005-06-16
JP4303596B2 (ja) 2009-07-29
DK1481059T3 (da) 2009-01-12
AU2003225578A1 (en) 2003-09-04
US8476040B2 (en) 2013-07-02
US7977068B2 (en) 2011-07-12
EP2060628B1 (de) 2011-11-16
AU2003225578B2 (en) 2008-04-03
US7972811B2 (en) 2011-07-05
US20110224102A1 (en) 2011-09-15
US20030162249A1 (en) 2003-08-28
US7094579B2 (en) 2006-08-22
JP5190963B2 (ja) 2013-04-24
US20100009857A1 (en) 2010-01-14
CA2475929A1 (en) 2003-08-21
US7396661B2 (en) 2008-07-08
EP1481059A4 (de) 2006-02-01
US20030228660A1 (en) 2003-12-11
DE60323210D1 (en) 2008-10-09
EP2060628A1 (de) 2009-05-20
US20080214411A1 (en) 2008-09-04
EP1481059B1 (de) 2008-08-27
ATE406439T1 (de) 2008-09-15
CA2475929C (en) 2013-01-15
DK2060628T3 (da) 2012-01-23
WO2003068956A1 (en) 2003-08-21
EP1481059A1 (de) 2004-12-01

Similar Documents

Publication Publication Date Title
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
EP1699920A4 (de) Neue rekombinante proteine mit freiem n-terminalem thiol
DE60325892D1 (de) Stellungs- und verwendungsverfahren
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
IL161016A (en) Polypeptides capable of ang-2 binding
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
HUP0301693A2 (hu) Antitest citokin-citokin inhibitorból (szelektokin) álló fúziós protein célspecifikus prodrugként történő alkalmazásra
TW200611910A (en) Interferon-alpha polypeptides and conjugates
NO20054836L (no) Nogo-reseptorbindingsprotein
CY1114526T1 (el) Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων
WO2002066653A3 (en) Procaryotic libraries and uses
ATE327328T1 (de) Adipozyten-spezifische protein homologe
ATE513040T1 (de) Zinkfingerdomänenbibliotheken
EA200800301A1 (ru) Протеины, связывающие il-6
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE60118935D1 (de) Dna & protein bindende miniatur proteine
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
ATE442444T1 (de) Glykosylphosphatidylinositolhaltige polypeptide
DE60221273D1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
WO2002059282A3 (en) Adipocyte complement related protein zacrp13
DE602004021922D1 (de) Induktion der blütenbildung
MY142798A (en) Methods for preventing glyconoylation of proteins
ATE417105T1 (de) Spleissvariante des kopftrauma induzierten zytoplasmatischen calcium-bindenden proteins